文献速递类风湿关节炎

类风湿关节炎成人康复剂量与基线因素及临床结局变化的关联

Examining Rehabilitation Dose in Adults With Rheumatoid Arthritis: Association With Baseline Factors and Change in Clinical Outcomes.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-01-18

基于美国风湿病数据库注册研究,纳入1381例新发康复治疗的类风湿关节炎成人,评估基线因素与康复剂量的关联及康复剂量与6个月后身体功能、疼痛、疲劳有意义变化的关系。基线身体功能较差与更高康复剂量相关;高剂量康复与身体功能改善相关,校正混杂后仅身体功能变化的关联持续存在。

要点

  • 基线身体功能较差者更可能接受高剂量康复(校正OR 1.29,95%CI 1.04-1.60)。
  • 高剂量康复与身体功能改善相关(校正OR 1.41,95%CI 1.03-1.92)。
  • 高剂量康复与疼痛和疲劳改善的关联在校正混杂后未持续存在。

核心结论

  • 使用真实世界数据,本研究支持对类风湿关节炎成人采用更高康复剂量以改善身体功能。

研究设计与样本

  • 基于美国风湿病数据库注册研究,纳入1381例新发康复治疗的类风湿关节炎成人,评估基线因素与康复剂量的关联及康复剂量与6个月后身体功能、疼痛、疲劳有意义变化的关系。

主要发现

  • 基线身体功能较差与更高康复剂量相关(校正OR 1.29,95%CI 1.04-1.60),而疼痛(校正OR 1.04,95%CI 0.99-1.10)和疲劳(校正OR 0.98,95%CI 0.93-1.03)与康复剂量无显著关联。
  • 与低剂量相比,高剂量康复与身体功能(OR 1.51,95%CI 1.14-1.98)、疼痛(OR 1.44,95%CI 1.06-1.96)和疲劳(OR 1.45,95%CI 1.06-1.99)的有利变化相关。
  • 校正混杂因素后,仅高剂量康复与身体功能变化的关联持续存在(校正OR 1.41,95%CI 1.03-1.92)。

关键数值与推荐

  • 康复剂量定义:低剂量为1-2次就诊,中剂量为3-8次就诊,高剂量为>8次就诊。
  • 样本中康复剂量分布:低剂量27%,中剂量42%,高剂量31%。
  • 临床结局变化分类为改善、无变化或恶化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association of baseline factors with rehabilitation dose and the association of rehabilitation dose with meaningful change in physical function, pain, and fatigue over 6 months among adults with rheumatoid arthritis (RA). METHODS: Using data from the National Databank for Rheumatic Diseases registry, we extracted baseline characteristics and self-reported physical function (Health Assessment Questionnaire), pain (visual analog scale [VAS]), fatigue (VAS), rehabilitation dose (low: 1-2 visits, medium: 3-8 visits, high: >8 visits), and follow-up outcomes 6 months later. Changes in clinical outcomes were categorized as improved, no change, or worsened. We calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) using proportional odds logistic regression models to examine the association of the baseline factors with rehabilitation dose and the association of rehabilitation dose with changes in clinical outcomes, adjusting for potential confounders. RESULTS: The sample included 1,381 adults with a new episode of rehabilitation (dose: low 27%, medium 42%, high 31%). Worse baseline physical function (adjusted OR 1.29 [95% CI 1.04-1.60]), but not pain (adjusted OR 1.04 [95% CI 0.99-1.10]) or fatigue (adjusted OR 0.98 [95% CI 0.93-1.03]), were associated with a higher rehabilitation dose. A high rehabilitation dose was associated with a favorable change in physical function (OR 1.51 [95% CI 1.14-1.98]), pain (OR 1.44 [95% CI 1.06-1.96]), and fatigue (OR 1.45 [95% CI 1.06-1.99]) compared to a low dose; only the association with physical function change persisted in adjusted models (adjusted OR 1.41 [95% CI 1.03-1.92]). CONCLUSION: Using real-world data, this study supports a higher rehabilitation dose to improve physical function in adults with RA.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Thoma LM, Wellsandt E, Wipfler K, et al. Examining Rehabilitation Dose in Adults With Rheumatoid Arthritis: Association With Baseline Factors and Change in Clinical Outcomes. Arthritis Care Res (Hoboken). 2023. PMID: 36094858. doi:10.1002/acr.25019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。